Elutia (ELUT) announced that it has entered into an agreement with Advantus Health Partners to provide access of Elutia’s EluPro Antibiotic Eluting BioEnvelope to Advantus’ core group purchasing organizations solutions portfolio.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELUT: